New diabetes pill shows promise in mexican study
NCT ID NCT05316662
First seen Nov 01, 2025 · Last updated May 02, 2026 · Updated 25 times
Summary
This study followed 187 adults with type 2 diabetes in Mexico who were already prescribed Rybelsus (oral semaglutide) by their doctors. The goal was to see how well the once-daily pill lowers blood sugar and affects body weight over 8-10 months. Participants completed questionnaires during regular checkups. The study did not provide treatment but observed real-world outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CICEJ Centro de Investigacion Clinica Endocrinologica de Jalisco SC
Guadalajara, Jalisco, 44670, Mexico
-
Centro de Investigacion Clinica Endocrinologica de Jalisco
Guadalajara, Jalisco, 44670, Mexico
Conditions
Explore the condition pages connected to this study.